Characterization of endothelin receptors in rat renal artery in vitro
Open Access
- 1 February 1995
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 114 (4) , 785-790
- https://doi.org/10.1111/j.1476-5381.1995.tb13273.x
Abstract
1 The aim of this study was to investigate the function and characteristics of endothelin receptors in rat main branch renal artery in vitro. 2 Endothelin(ET)-1 (mean EC50 = 9.8 nm) was approximately 12 fold more potent than ET-3 (mean EC50 = 120 nm) as a contractile agonist and produced a greater maximum response. In contrast, neither of the ETB receptor-selective agonists, alanine1,13,11,15] ET-1 nor sarafotoxin S6c, (0.1 nm-1 μm), induced any contractile effect, or any relaxant effect in endothelium-intact preparations pre-contracted with the thromboxane A2 mimetic, U-46619. Sarafotoxin S6c (30 nm) also failed to induce any further contraction in tissues pre-contracted with an EC50 concentration of ET-1. 3 The ETA receptor-selective antagonist, BQ123, behaved as a weak and variable antagonist of the contractile effects of ET-1 (mean pA2 estimates in the range 5.8–6.3). In contrast, BQ123 antagonized ET-3 with a potency (mean pA2 = 7.6) consistent with its affinity for ETA receptors. Co-incubation of BQ123 (3 μm) with the putative ETB receptor-selective antagonist, IRL1038 (10 μm), produced no greater antagonism of ET-1 responses than was induced by BQ123 (3 μm) alone. 4 In conclusion, ETB receptors do not appear to be present in rat main branch renal artery. The contractile effects of ET-3 in this tissue seem to be mediated by ETA receptors. While ETA receptors partly mediate the contractile effects of ET-1, these data raise the possibility that a population of novel BQ123-insensitive endothelin receptors may also contribute to this response.Keywords
This publication has 39 references indexed in Scilit:
- Retraction concerning an endothelin B receptor‐selective antagonist: Urade, Y., Fujitani, Y., Oda, K., Watakabe, T., Umemura, L., Takai, M., Okada, T., Sakata, K. and Karaki, H. (1992) FEBS Lett. 311, 12‐16FEBS Letters, 1994
- ETA and ETB Receptors Coexist on Rabbit Pulmonary Artery Vascular Smooth Muscle Mediating ContractionBiochemical and Biophysical Research Communications, 1993
- Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptorLife Sciences, 1992
- An endothelin B receptor‐selective antagonist: IRL 1038, [Cys11‐Cys15]‐endothelin‐1(11–21)FEBS Letters, 1992
- Venous smooth muscle contains vasoconstrictor ETB-like receptorsBiochemical and Biophysical Research Communications, 1992
- [Ala1,3,11,15]endothelin-1 analogs with ETB agonistic activityBiochemical and Biophysical Research Communications, 1991
- Sarafotoxin S6c: An agonist which distinguishes between endothelin receptor subtypesBiochemical and Biophysical Research Communications, 1991
- Contractile responses of the human urinary bladder, renal pelvis and renal artery to endothelins and sarafotoxin S6bGeneral Pharmacology: The Vascular System, 1990
- Cellular mechanism of action by a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cellsBiochemical and Biophysical Research Communications, 1988
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980